商务合作
动脉网APP
可切换为仅中文
PARSIPPANY, N.J.
新泽西州帕西帕尼
,
,
June 18, 2026
2026年6月18日
/PRNewswire/ -- EBI, the pioneer of electrobiology innovations, today announced the acquisition of Xstim, a division of Precision Medical Products Inc., focused on developing next generation bone growth stimulation solutions. EBI is a portfolio company of Avista Healthcare Partners, a leading middle-market healthcare private equity firm with over 20 years of experience in building growth-oriented healthcare businesses..
/美通社/ -- 电生物学创新先驱EBI今日宣布收购Precision Medical Products Inc.旗下专注于开发下一代骨生长刺激解决方案的部门Xstim。EBI是Avista Healthcare Partners旗下的投资组合公司,后者是一家领先的中端市场医疗保健私募股权公司,在构建增长导向型医疗保健企业方面拥有超过20年的经验。
The acquisition of Xstim enhances EBI's comprehensive bone growth stimulation portfolio with a next generation, modern, wearable, non-invasive spine fusion stimulation therapy designed to support patient comfort, ease of use, and clinical confidence. By adding Xstim's capacitively coupled electrical stimulation technology to EBI's established platform of non-surgical and implantable bone healing solutions, EBI is positioned to offer surgeons, patients, and care teams a broader range of clinically supported options across lumbar spinal fusion, nonunion fracture, and failed joint fusion applications.
收购Xstim增强了EBI全面的骨生长刺激产品组合,增加了一种下一代、现代化、可穿戴、非侵入性的脊柱融合刺激疗法,旨在提升患者舒适度、使用便捷性和临床信心。通过将Xstim的电容耦合电刺激技术添加到EBI已有的非手术和植入式骨愈合解决方案平台中,EBI能够为外科医生、患者和护理团队在腰椎融合、骨折不愈合以及关节融合失败等应用中提供更广泛的临床支持选项。
By combining EBI's comprehensive portfolio of bone growth stimulation solutions with Xstim's innovative technology platform, the company is well positioned to advance the next generation of bone healing innovation and expand treatment options for physicians and patients..
通过将EBI全面的骨生长刺激解决方案产品组合与Xstim的创新技术平台相结合,该公司已具备有利条件,能够推动下一代骨愈合创新的发展,并为医生和患者拓展治疗选择。
EBI's Chief Executive Officer, Kevin Kenny, shared, 'Our vision is clear: to be the trusted market leader in bone growth stimulation, dedicated to partnering with physicians to improve their patients' bone healing outcomes. The addition of Xstim further supports our mission by introducing next generation products, strengthening our portfolio and expanding our R&D pipeline focused on today's modern needs for both surgeons and patients.'.
EBI首席执行官Kevin Kenny表示:“我们的愿景明确:成为骨生长刺激领域值得信赖的市场领导者,致力于与医师合作,改善患者的骨愈合效果。Xstim的加入进一步支持了我们的使命,通过引入下一代产品,强化我们的产品组合,并扩展针对外科医生和患者现代需求的研发管线。”
Ropes & Gray LLP served as legal counsel to EBI. William Blair served as exclusive financial advisor and Perkins Coie served as legal counsel to Precision Medical Products, Inc.
Ropes & Gray LLP 担任 EBI 的法律顾问。William Blair 担任独家财务顾问,Perkins Coie 担任 Precision Medical Products, Inc. 的法律顾问。
ABOUT EBI
关于EBI
For over 45 years, EBI has been at the forefront of electrobiology innovations, offering the largest and most robust portfolio of clinically proven implantable and non-invasive bone growth stimulation solutions. As the only pure-play bone growth stimulation company, EBI provides unique technologies and products that specifically target the challenges faced with nonhealing fractures, joint fusions, and high-risk spinal fusion patients.
45多年来,EBI一直走在电生物学创新的前沿,提供规模最大、最可靠的经临床验证的植入式和非侵入式骨生长刺激解决方案组合。作为唯一一家专注于骨生长刺激的公司,EBI提供独特的技术和产品,专门针对骨折不愈合、关节融合以及高风险脊柱融合患者所面临的挑战。
Since its pioneering product launch in 1979, EBI has been leading in the industry in bone growth stimulation innovation. For more information, visit .
自1979年推出开创性产品以来,EBI一直在骨生长刺激创新领域处于行业领先地位。欲了解更多信息,请访问。
www.ebibonestimulator.com
www.ebibonestimulator.com
.
。
MARKET LEADERSHIP
市场领导地位
EBI's portfolio includes FDA-approved and cleared bone growth stimulation solutions used across spinal fusion, nonunion fracture, and joint fusion applications, including EBI
EBI 的产品组合包括获得美国食品药品监督管理局(FDA)批准和许可的骨生长刺激解决方案,广泛应用于脊柱融合、骨不连骨折以及关节融合等领域,其中包括 EBI
®
®
Bone Healing System, OsteoGen™, OrthoPak
骨愈合系统,OsteoGen™,OrthoPak
®
®
, SpF
,SpF
®
®
, SpinalPak
,SpinalPak
®
®
, and now Xstim™.
,以及现在的 Xstim™。
EBI is committed to its mission of Helping People Heal™ by delivering quality bone growth solutions, clinical excellence, superior service, and making a meaningful impact in patients' lives. Learn more at
EBI 致力于通过提供优质的骨生长解决方案、卓越的临床水平、优质的服务,并对患者的生活产生有意义的影响,来践行其“帮助人们康复™”的使命。了解更多请访问
www.ebibonestimulator.com
www.ebibonestimulator.com
and follow EBI on
并关注 EBI 的
领英
.
。
ABOUT XSTIM
关于 XSTIM
Xstim was the bone healing division of Precision Medical Products focused on developing non-invasive bone growth stimulation solutions. Its wearable spine fusion therapy uses capacitively coupled electrical stimulation to support bone healing following lumbar spinal fusion and is highly complementary to EBI's broader bone growth stimulation portfolio..
Xstim 是 Precision Medical Products 旗下的骨愈合部门,专注于开发非侵入式骨生长刺激解决方案。其可穿戴脊柱融合疗法采用电容耦合电刺激技术,以支持腰椎脊柱融合术后的骨愈合,与 EBI 更广泛的骨生长刺激产品组合高度互补。
ABOUT AVISTA HEALTHCARE PARTNERS
关于阿维斯塔医疗合作伙伴
Avista Healthcare Partners, founded in 2005 by
Avista Healthcare Partners,成立于2005年,由
Thompson Dean
汤普森·迪恩
and
和
David Burgstahler
大卫·伯格斯泰勒
, is a leading New York-based private equity firm with over $10 billion invested in more than 50 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects – targeting healthcare product and technology businesses with clear scale potential across four sub-sectors experiencing strong tailwinds.
Avista 是一家总部位于纽约的领先私募股权公司,已在全球50多家以增长为导向的医疗保健企业中投资超过100亿美元。Avista 与拥有强大管理团队、稳定现金流和强劲增长前景的企业建立合作伙伴关系,重点聚焦于在四个享有强劲顺风的细分领域中具有明确规模化潜力的医疗保健产品和技术企业。
The team is supported by a group of seasoned Strategic Executives enhancing the entire investment process through strategic insight, long-term value and sustainable businesses. For more information, visit .
该团队由一群经验丰富的战略高管提供支持,他们通过战略洞察、长期价值和可持续业务来优化整个投资流程。欲了解更多信息,请访问。
www.avistahealthcare.com
www.avistahealthcare.com
and follow Avista on
并在上关注 Avista
领英
.
。
For media inquiries, please contact:
媒体垂询,请联系:
Daniel Yunger / James Lindsay
丹尼尔·荣格 / 詹姆斯·林赛
Kekst CNC
凯克斯特CNC
[email protected]
[email protected]
/
/
[email protected]
[email protected]
917.574.8582 / 917.842.4119
917.574.8582 / 917.842.4119
SOURCE Avista Healthcare Partners
来源:Avista Healthcare Partners
21
二十一
%
%
more press release views with
更多新闻稿浏览量,通过
Request a Demo
请求演示